1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Sinus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, SK; Jeon, SY; Kim, BG; Kim, EA; Kim, JP | 1 |
| Furukawa, M; Kumazawa, T; Saito, K; Satouchi, K; Yamashita, T | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Sinus Infections
| Article | Year |
|---|---|
Rat model of platelet-activating factor-induced rhinosinusitis.
Topics: Administration, Intranasal; Animals; Autacoids; Disease Models, Animal; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Rhinitis; Sinusitis | 2005 |
Evidence of platelet-activating factor in nasal polyps.
Topics: Adolescent; Adult; Aged; Antibodies, Anti-Idiotypic; Calcimycin; Child; Chronic Disease; Female; Humans; Immunoglobulin E; Male; Middle Aged; Nasal Polyps; Phospholipids; Platelet Activating Factor; Platelet Aggregation; Sinusitis | 1992 |